{
  "id": 10605395,
  "title": "Celltrion to seek new drug, CDMO partners at int'l pharmaceutical exhibition in Milan",
  "url": "https://urgent.news/2026/09/29/celltrion-to-seek-new-drug-cdmo-partners-at-intl-pharmaceutical",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-29T04:17:03.000Z",
  "source": {
    "name": "The Korea Times",
    "slug": "the-korea-times",
    "url": "https://www.koreatimes.co.kr/business/companies/20260929/celltrion-to-seek-new-drug-cdmo-partners-at-intl-pharmaceutical-exhibition-in-milan"
  },
  "original_language": "en",
  "account": "Celltrion plans to seek new drug development, contract manufacturing, and supply chain partners at the upcoming CPHI Worldwide pharmaceutical trade show in Milan, the Korean biopharmaceutical company announced on Tuesday. The company will participate in the 37th edition of the CPHI Worldwide event, which takes place from October 6-8 and attracts more than 60,000 industry professionals from around 2,400 companies across 170 countries.\n\nCelltrion, renowned for its biosimilars, aims to explore partnerships in oncology, obesity, metabolic diseases, and autoimmune diseases. The company recently began making progress in new drug research in these areas, positioning itself for global drug development. As the demand for its core products escalates, Celltrion intends to bolster its existing alliances with overseas raw material suppliers and contract manufacturers.",
  "summary": "Celltrion will use one of the world's largest pharmaceutical trade shows next month to seek partners in new drug development, contract manufacturing and supply chains, the Korean biopharmaceutical company said Tuesday. The company will take part in CPHI Worldwide, which runs Oct. 6-8 in Milan. Now in its 37th year, the event covers pharmaceutical manufacturing, supply chains and contract…",
  "key_points": [
    "Celltrion to seek new drug development partners at CPHI Milan exhibition",
    "Company aims to explore collaborations in oncology, obesity, metabolic, and autoimmune diseases",
    "Celltrion recently made progress in new drug research for these disease areas"
  ],
  "editors_take": "Celltrion's participation in the CPHI Worldwide event signals its push to expand partnerships in key therapeutic areas, bolstering its global drug development and supply chain capabilities.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Korea Times",
        "title": "Celltrion to seek new drug, CDMO partners at int'l pharmaceutical exhibition in Milan",
        "url": "https://urgent.news/2026/09/29/celltrion-to-seek-new-drug-cdmo-partners-at-intl-pharmaceutical-10608833",
        "published": "2026-09-29T04:47:03.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}